Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -2.87M | -3.05M | -2.48M | -2.56M | -4.37M |
| Total Depreciation and Amortization | 3.20K | 3.50K | 3.10K | 2.90K | 3.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 1.37M |
| Total Other Non-Cash Items | 184.00K | 598.50K | 227.90K | 200.70K | 255.20K |
| Change in Net Operating Assets | 554.30K | 21.60K | -866.10K | 711.80K | 166.80K |
| Cash from Operations | -2.13M | -2.43M | -3.11M | -1.65M | -2.57M |
| Capital Expenditure | -9.60K | -3.90K | -4.30K | -3.60K | -1.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -400.00K |
| Cash from Investing | -9.60K | -3.90K | -4.30K | -3.60K | -401.50K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 18.84M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -1.55M |
| Cash from Financing | -- | -- | -- | 0.00 | 17.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.14M | -2.43M | -3.12M | -1.65M | 14.31M |
